Depressed plasma activity of plasminogen or α2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation

被引:8
作者
Asakura, H
Ontachi, Y
Mizutani, T
Kato, M
Ito, T
Saito, M
Morishita, E
Yamazaki, M
Suga, Y
Miyamoto, KI
Nakao, S
机构
[1] Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Sch Med, Hosp Pharm, Kanazawa, Ishikawa 920, Japan
关键词
disseminated intravascular coagulation; sepsis; plasminogen; alpha 2 plasmin inhibitor; consumption coagulopathy;
D O I
10.1097/00001721-200106000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have attempted to determine whether depressed plasma plasminogen and alpha2 plasmin inhibitor (or alpha2 antiplasmin) activity is, as a result of consumption coagulopathy, a specific finding of disseminated intravascular coagulation (DIC) in septic patients. The hemostatic parameters of 139 septic patients (68 with DIC and 71 without DIG) were analyzed. Among the group as a whole, plasma activities of plasminogen and alpha2 plasmin inhibitor were significantly depressed in septic patients with DIC relative to those without DIC (P < 0.01 and P < 0.05, respectively). Notably, a significant correlation was observed between plasma levels of albumin and plasminogen activity, as well as between plasma levels of albumin and alpha2 plasmin inhibitor activity both in septic patients with DIC and those without DIG. However, no significant correlation was observed between plasma levels of plasmin-alpha2 plasmin inhibitor complex (PIC) and plasminogen activity, nor between PIC and alpha2 plasmin inhibitor activity either in septic patients with DIC or those without DIG. We concluded that depressed activity of plasminogen or alpha2 plasmin inhibitor is not as a result of consumption coagulopathy, but rather a result of low synthetic function of the liver in septic patients with DIG. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 31 条
[1]   CHANGES IN PLASMA-LEVELS OF TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR COMPLEX AND ACTIVE PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION [J].
ASAKURA, H ;
JOKAJI, H ;
SAITO, M ;
UOTANI, C ;
KUMABASHIRI, I ;
MORISHITA, E ;
YAMAZAKI, M ;
MATSUDA, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 36 (03) :176-183
[2]   PLASMA-LEVELS OF SOLUBLE THROMBOMODULIN INCREASE IN CASES OF DISSEMINATED INTRAVASCULAR COAGULATION WITH ORGAN FAILURE [J].
ASAKURA, H ;
JOKAJI, H ;
SAITO, M ;
UOTANI, C ;
KUMABASHIRI, I ;
MORISHITA, E ;
YAMAZAKI, M ;
MATSUDA, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (04) :281-287
[3]   STUDY OF THE BALANCE BETWEEN COAGULATION AND FIBRINOLYSIS IN DISSEMINATED INTRAVASCULAR COAGULATION USING MOLECULAR MARKERS [J].
ASAKURA, H ;
JOKAJI, H ;
SAITO, M ;
UOTANI, C ;
KUMABASHIRI, I ;
MORISHITA, E ;
YAMAZAKI, M ;
AOSHIMA, K ;
MATSUDA, T .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) :829-832
[4]  
Bick RL, 1999, HAEMOSTASIS, V29, P111
[5]  
BLOMBACK M, 1985, SCAND J CLIN LAB INV, V45, P15
[6]  
Carey MJ, 1998, AM J HEMATOL, V59, P65, DOI 10.1002/(SICI)1096-8652(199809)59:1<65::AID-AJH13>3.0.CO
[7]  
2-0
[8]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[9]   AN IMMUNOLOGICAL METHOD FOR DEMONSTRATING FIBRIN DEGRADATION PRODUCTS IN SERUM AND ITS USE IN DIAGNOSIS OF FIBRINOLYTIC STATES [J].
FERREIRA, HC ;
MURAT, LG .
BRITISH JOURNAL OF HAEMATOLOGY, 1963, 9 (03) :299-&
[10]   SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES [J].
FOURRIER, F ;
CHOPIN, C ;
GOUDEMAND, J ;
HENDRYCX, S ;
CARON, C ;
RIME, A ;
MAREY, A ;
LESTAVEL, P .
CHEST, 1992, 101 (03) :816-823